Brown Capital Management’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.47M	Sell	1,480,506 -592,409	-29%	-$2.8M	0.92%	32
2025 Q4	$10.5M	Sell	2,072,915 -2,885,101	-58%	-$13.4M	0.86%	36
2025 Q3	$17.2M	Sell	4,958,016 -2,151,979	-30%	-$8.08M	0.71%	41
2025 Q2	$24.2M	Sell	7,109,995 -353,972	-5%	-$1.18M	0.7%	41
2025 Q1	$29.9M	Sell	7,463,967 -782,643	-9%	-$4.06M	0.9%	39
2024 Q4	$53.5M	Sell	8,246,610 -1,246,864	-13%	-$7.43M	1.24%	30
2024 Q3	$52.6M	Sell	9,493,474 -1,893,910	-17%	-$10.7M	1.13%	31
2024 Q2	$63.5M	Sell	11,387,384 -634,630	-5%	-$3.81M	1.28%	25
2024 Q1	$80.7M	Buy	12,022,014 +5,689	+0%	+$45K	1.43%	26
2023 Q4	$110M	Sell	12,016,325 -1,544,155	-11%	-$9.72M	1.64%	24
2023 Q3	$74.9M	Buy	13,560,480 +2,828,797	+26%	+$22.7M	1.15%	31
2023 Q2	$91.6M	Buy	10,731,683 +2,130,260	+25%	+$19.1M	1.3%	30
2023 Q1	$79M	Buy	8,601,423 +3,493,545	+68%	+$37.6M	1.18%	31
2022 Q4	$52.2M	Buy	5,107,878 +701,417	+16%	+$9.43M	0.86%	32
2022 Q3	$64.9M	Buy	+4,406,461	New	+$57.2M	0.91%	32